Lone Pine Capital LLC
CIK 0001061165
Portfolio value
$16.36BQ2 2026
Quarterly filings
| Year | Quarter | Portfolio value | Positions | Largest holding |
|---|---|---|---|---|
| 2026 | Q2 2026 filed Aug 14, 2026 | $16.36B | 34 | NBIS 7.2% |
| Q1 2026 filed May 15, 2026 | $12.54B | 36 | VST 7.4% | |
| 2025 | Q4 2025 filed Feb 17, 2026 | $13.61B | 32 | TSM 6.8% |
| Q3 2025 filed Nov 14, 2025 | $13.74B | 25 | META 7.1% | |
| Q2 2025 filed Aug 14, 2025 | $14.05B | 24 | VST 8.9% | |
| Q1 2025 filed May 15, 2025 | $11.58B | 24 | META 8.8% | |
| 2024 | Q4 2024 filed Feb 14, 2025 | $13.47B | 30 | META 8.9% |
| Q3 2024 filed Nov 14, 2024 | $13.41B | 29 | META 8.1% | |
| Q2 2024 filed Aug 14, 2024 | $12.33B | 24 | TSM 8.5% | |
| Q1 2024 filed May 15, 2024 | $12.67B | 26 | META 8.2% | |
| 2023 | Q4 2023 filed Feb 14, 2024 | $11.56B | 25 | META 8.8% |
| Q3 2023 filed Nov 14, 2023 | $10.37B | 26 | META 8.0% | |
| Q2 2023 filed Aug 14, 2023 | $10.91B | 29 | MSFT 7.8% | |
| Q1 2023 filed May 15, 2023 | $10.80B | 29 | WDAY 8.2% | |
| 2022 | Q4 2022 filed Feb 14, 2023 | $10.48B | 30 | BBWI 8.3% |
| Q3 2022 filed Nov 14, 2022 | $10.61B | 31 | WDAY 7.2% | |
| Q2 2022 filed Aug 15, 2022 | $10.61B | 30 | AMZN 9.0% | |
| Q1 2022 filed May 16, 2022 | $16.81B | 30 | MSFT 9.2% | |
| 2021 | Q4 2021 filed Feb 14, 2022 | $24.41B | 29 | AMZN 8.4% |
| Q3 2021 filed Nov 15, 2021 | $29.68B | 39 | SHOP 6.5% | |
| Q2 2021 filed Nov 15, 2021 | $31.03B | 35 | SHOP 7.7% | |
| Q1 2021 filed May 17, 2021 | $27.53B | 38 | SHOP 6.9% | |
| 2020 | Q4 2020 filed Feb 16, 2021 | $27.51B | 41 | SHOP 7.4% |
| Q3 2020 filed Feb 16, 2021 | $23.28B | 32 | SHOP 7.6% | |
| Q2 2020 filed Aug 14, 2020 | $19.79B | 29 | SHOP 8.0% | |
| Q1 2020 filed May 15, 2020 | $16.85B | 39 | BABA 7.3% | |
| 2019 | Q4 2019 filed Feb 14, 2020 | $18.86B | 43 | BABA 7.0% |
| Q3 2019 filed Nov 14, 2019 | $17.00B | 37 | BABA 7.2% | |
| Q2 2019 filed Aug 14, 2019 | $16.08B | 31 | ADBE 6.9% | |
| Q1 2019 filed May 15, 2019 | $17.11B | 29 | ADBE 7.1% | |
| 2018 | Q4 2018 filed Feb 14, 2019 | $14.77B | 25 | ADBE 7.9% |
| Q3 2018 filed Nov 14, 2018 | $19.44B | 25 | BABA 8.2% | |
| Q2 2018 filed Aug 14, 2018 | $18.91B | 28 | MSFT 6.5% | |
| Q1 2018 filed May 15, 2018 | $19.74B | 30 | META 6.2% | |
| 2017 | Q4 2017 filed Feb 14, 2018 | $19.16B | 31 | STZ 5.8% |
| Q3 2017 filed Nov 14, 2017 | $20.57B | 31 | BABA 7.4% | |
| Q2 2017 filed Aug 14, 2017 | $19.67B | 33 | BABA 8.4% | |
| Q1 2017 filed May 15, 2017 | $19.01B | 34 | CHTR 9.8% | |
| 2016 | Q4 2016 filed Feb 14, 2017 | $19.16B | 41 | CHTR 7.1% |
| Q3 2016 filed Nov 14, 2016 | $22.40B | 40 | CHTR 6.3% | |
| Q2 2016 filed Aug 15, 2016 | $21.67B | 38 | PRICELINE GRP INC 6.5% | |
| Q1 2016 filed May 16, 2016 | $20.10B | 41 | MSFT 7.1% | |
| 2015 | Q4 2015 filed Feb 16, 2016 | $23.40B | 47 | MSFT 6.5% |
| Q3 2015 filed Nov 16, 2015 | $24.55B | 52 | VALEANT PHARMACEUTICALS INTL 5.4% | |
| Q2 2015 filed Aug 14, 2015 | $26.73B | 56 | CURRENCYSHARES EURO TR PUT 8.2% | |
| Q1 2015 filed May 15, 2015 | $26.42B | 54 | CURRENCYSHARES EURO TR PUT 8.0% | |
| 2014 | Q4 2014 filed Feb 17, 2015 | $23852.92B | 48 | MA 7.2% |
| Q3 2014 filed Nov 14, 2014 | $25.59B | 48 | BIDU 7.0% | |
| Q2 2014 filed Aug 14, 2014 | $24.74B | 53 | BIDU 6.7% | |
| Q1 2014 filed May 15, 2014 | $23.00B | 52 | CTSH 6.3% | |
| 2013 | Q4 2013 filed Feb 14, 2014 | $23.25B | 55 | DG 4.9% |
| Q3 2013 filed Nov 14, 2013 | $22.40B | 57 | DG 4.5% | |
| Q2 2013 filed Aug 14, 2013 | $20.53B | 59 | PRICELINE COM INC 6.9% |
Holdings reflect long positions disclosed in 13F filings only and exclude short positions, cash, and other non-13F assets. Holdings data sourced from SEC EDGAR. Not investment advice. Full disclaimer.